JPWO2019131829A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019131829A5
JPWO2019131829A5 JP2019562142A JP2019562142A JPWO2019131829A5 JP WO2019131829 A5 JPWO2019131829 A5 JP WO2019131829A5 JP 2019562142 A JP2019562142 A JP 2019562142A JP 2019562142 A JP2019562142 A JP 2019562142A JP WO2019131829 A5 JPWO2019131829 A5 JP WO2019131829A5
Authority
JP
Japan
Prior art keywords
seq
rna
nucleic acid
cell
guide rna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019562142A
Other languages
English (en)
Japanese (ja)
Other versions
JP7288282B2 (ja
JPWO2019131829A1 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2018/048034 external-priority patent/WO2019131829A1/ja
Publication of JPWO2019131829A1 publication Critical patent/JPWO2019131829A1/ja
Publication of JPWO2019131829A5 publication Critical patent/JPWO2019131829A5/ja
Application granted granted Critical
Publication of JP7288282B2 publication Critical patent/JP7288282B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019562142A 2017-12-28 2018-12-27 標的遺伝子改変用組成物 Active JP7288282B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2017254798 2017-12-28
JP2017254798 2017-12-28
PCT/JP2018/048034 WO2019131829A1 (ja) 2017-12-28 2018-12-27 標的遺伝子改変用組成物

Publications (3)

Publication Number Publication Date
JPWO2019131829A1 JPWO2019131829A1 (ja) 2021-02-04
JPWO2019131829A5 true JPWO2019131829A5 (https=) 2022-01-12
JP7288282B2 JP7288282B2 (ja) 2023-06-07

Family

ID=67067613

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019562142A Active JP7288282B2 (ja) 2017-12-28 2018-12-27 標的遺伝子改変用組成物

Country Status (9)

Country Link
US (1) US12031130B2 (https=)
EP (1) EP3733844B1 (https=)
JP (1) JP7288282B2 (https=)
KR (1) KR102799255B1 (https=)
CN (1) CN111527204B (https=)
AU (1) AU2018397951B2 (https=)
CA (1) CA3086885A1 (https=)
TW (1) TWI825057B (https=)
WO (1) WO2019131829A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9828582B2 (en) 2013-03-19 2017-11-28 Duke University Compositions and methods for the induction and tuning of gene expression
WO2016130600A2 (en) 2015-02-09 2016-08-18 Duke University Compositions and methods for epigenome editing
KR102787119B1 (ko) 2015-11-30 2025-03-27 듀크 유니버시티 유전자 편집에 의한 인간 디스트로핀 유전자의 교정을 위한 치료용 표적 및 사용 방법
US20190127713A1 (en) 2016-04-13 2019-05-02 Duke University Crispr/cas9-based repressors for silencing gene targets in vivo and methods of use
JP7490211B2 (ja) 2016-07-19 2024-05-27 デューク ユニバーシティ Cpf1に基づくゲノム編集の治療適用
US20200331841A1 (en) 2017-12-28 2020-10-22 Takeda Pharmaceutical Company Limited Cationic lipids
EP3740580A4 (en) 2018-01-19 2021-10-20 Duke University GENOME ENGINEERING WITH CRISPR-CAS SYSTEMS IN EUKARYONTS
EP3842538A4 (en) * 2018-08-10 2022-06-08 Kyoto University METHOD OF TRANSFECTION INTO CARDIOMYOCYTES USING CATIONIC LIPID
US12479791B2 (en) 2018-08-10 2025-11-25 Takeda Pharmaceutical Company Limited Cationic lipid
TW202208626A (zh) * 2020-04-24 2022-03-01 美商生命編輯公司 Rna引導核酸酶及其活性片段與變體,以及使用方法
EP4225907A4 (en) * 2020-10-12 2025-01-22 Duke University CRISPR/CAS-BASED BASE EDITING COMPOSITION TO RESTORE DYSTROPHIN FUNCTION
CN113528437B (zh) * 2021-07-07 2023-08-25 中国医学科学院血液病医院(中国医学科学院血液学研究所) 一种增强基因编辑效率的试剂盒及其应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7223887B2 (en) 2001-12-18 2007-05-29 The University Of British Columbia Multivalent cationic lipids and methods of using same in the production of lipid particles
AU2003240978A1 (en) 2002-05-31 2003-12-19 Genteric, Inc. Multi-functional polyamines for delivery of biologically-active polynucleotides
US8969543B2 (en) 2003-04-03 2015-03-03 Bioneer Corporation SiRNA-hydrophilic polymer conjugates for intracellular delivery of siRNA and method thereof
CA2532228C (en) 2003-07-16 2017-02-14 Protiva Biotherapeutics, Inc. Lipid encapsulated interfering rna
JP4764426B2 (ja) 2004-06-07 2011-09-07 プロチバ バイオセラピューティクス インコーポレイティッド カチオン性脂質および使用方法
CN107028886A (zh) 2009-11-04 2017-08-11 不列颠哥伦比亚大学 含有核酸的脂质粒子及相关的方法
KR101773643B1 (ko) 2010-04-28 2017-08-31 교와 핫꼬 기린 가부시키가이샤 양이온성 지질
WO2012028524A2 (en) 2010-08-30 2012-03-08 F. Hoffmann-La Roche Ag Method for producing a lipid particle, the lipid particle itself and its use
JP6108197B2 (ja) 2012-07-02 2017-04-05 日油株式会社 三級アミノ基含有脂質の製造方法
WO2014197748A2 (en) 2013-06-05 2014-12-11 Duke University Rna-guided gene editing and gene regulation
EP3470089A1 (en) * 2013-12-12 2019-04-17 The Broad Institute Inc. Delivery, use and therapeutic applications of the crispr-cas systems and compositions for targeting disorders and diseases using particle delivery components
EP3093283B1 (en) 2014-01-09 2018-12-19 Eisai R&D Management Co., Ltd. Cationic lipid
US20170015994A1 (en) * 2014-02-24 2017-01-19 Massachusetts Institute Of Technology Methods for in vivo genome editing
CN104116643B (zh) * 2014-07-10 2016-08-24 上海应用技术学院 一种包覆曲酸双棕榈酸酯的纳米固体脂质载体及制备方法
KR101882634B1 (ko) 2014-08-07 2018-07-26 다케다 야쿠힝 고교 가부시키가이샤 양이온성 지질
CN106714845A (zh) 2014-08-11 2017-05-24 得克萨斯州大学系统董事会 通过crispr/cas9介导的基因编辑预防肌营养不良
JP7242180B2 (ja) * 2014-09-07 2023-03-20 セレクタ バイオサイエンシーズ インコーポレーテッド 抗ウイルス導入ベクター免疫応答を減弱化するための方法および組成物
EP3275448B1 (en) 2015-03-24 2025-10-29 Kyowa Kirin Co., Ltd. Nucleic acid-containing lipid nanoparticles
CN104873976B (zh) 2015-05-08 2016-04-20 厦门成坤生物技术有限公司 一类阳离子类脂化合物的应用
WO2016197133A1 (en) * 2015-06-04 2016-12-08 Protiva Biotherapeutics, Inc. Delivering crispr therapeutics with lipid nanoparticles
AU2016344609B2 (en) 2015-10-28 2022-05-12 Vertex Pharmaceuticals Incorporated Materials and methods for treatment of duchenne muscular dystrophy
TWI894123B (zh) 2017-12-27 2025-08-21 日商武田藥品工業有限公司 含核酸之脂質奈米粒子及其用途

Similar Documents

Publication Publication Date Title
JPWO2019131829A5 (https=)
US20240083842A1 (en) Lipocationic dendrimers and uses thereof
US20240117347A1 (en) Oligonucleotide compositions and methods thereof
JP7696694B2 (ja) 修飾されたガイドrna
JP7068821B2 (ja) 化学修飾を有するガイドrna
CN118234867A (zh) 用于产生环状多核糖核苷酸的组合物和方法
AU2025205362A1 (en) Systems, methods, and compositions for targeted nucleic acid editing
US20200056207A1 (en) Methods and products for expressing proteins in cells
JP2026062702A5 (https=)
JP2022519019A (ja) オリゴヌクレオチド組成物及びその方法
CN104876831B (zh) 脂质修饰精胺衍生物及利用该衍生物制备的脂质体
JP2018503386A5 (https=)
CN104651398A (zh) 利用CRISPR-Cas9特异敲出microRNA基因家族的方法
JP2021525740A (ja) ビタミンカチオン性脂質
JP2018518182A5 (https=)
JP2016500262A5 (https=)
CN106957858A (zh) 一种利用CRISPR/Cas9系统共同敲除绵羊MSTN、ASIP、BCO2基因的方法
JP2019521659A (ja) ゲノム編集分子の細胞内送達のためのペプチドおよびナノ粒子
IL256169B2 (en) Oligonucleotides with a defined number of polymers and methods of their preparation
JP2018512162A5 (https=)
CN104619848A (zh) 细胞转染方法
TW201938202A (zh) 標的基因改變用組成物
DK2655620T3 (en) DNA expression construct
RU2020100919A (ru) СПОСОБ НОКАУТИРОВАНИЯ ГЕНА-МИШЕНИ В T-КЛЕТКЕ IN VITRO И crRNA, ПРИМЕНЯЕМАЯ В ДАННОМ СПОСОБЕ
JP2025505732A (ja) キロ塩基スケールでのrnaガイドゲノムリコンビニアリング